Literature DB >> 31047823

Therapeutic plasma apheresis: Expertise and indications.

Djuna Z de Back1, Marleen M Neyrinck2, Hans Vrielink3.   

Abstract

Therapeutic apheresis is an extracorporeal treatment that is capable of removing pathogenic blood components from patients that causes morbidity. In this review an overview is given of the types of indications for which therapeutic plasma exchange is effective. Furthermore, practical and effective topics, as well as complications will be discussed.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apheresis; Exchange; Extracorporeal; Plasma; Therapeutic

Mesh：

Year:  2019        PMID： 31047823     DOI： 10.1016/j.transci.2019.04.008

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN： 1473-0502            Impact factor:   1.764


  3 in total

1.  Protocol of comparison of the effects of single plasma exchange and double filtration plasmapheresis on peripheral lymphocyte phenotypes in patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a monocentric prospective study with single-case experimental design.

Authors:  O Moranne; I M Ion; R Cezar; Z Messikh; C Prelipcean; S Chkair; E Thouvenot; Tu Anh Tran; P Corbeau; T Chevallier
Journal:  BMC Neurol       Date:  2022-08-05       Impact factor: 2.903

2.  Therapeutic plasma exchange in the intensive care unit and with the critically ill, a focus on clinical nursing considerations.

Authors:  Ian Baldwin; Sarah Todd
Journal:  J Clin Apher       Date:  2022-04-06       Impact factor: 2.605

3.  Capsid-specific removal of circulating antibodies to adeno-associated virus vectors.

Authors:  Berangere Bertin; Philippe Veron; Christian Leborgne; Otto Merten; Federico Mingozzi; Jack-Yves Deschamps; Sophie Moullec; Yves Fromes; Fanny Collaud; Sylvie Boutin; Virginie Latournerie; Laetitia van Wittenberghe; Benoit Delache; Roger Le Grand; Nathalie Dereuddre-Bosquet; Olivier Benveniste; Philippe Moullier; Carole Masurier
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.